Creatine kinase (CK; EC 2.7.3.2) isoenzyme BB extracted from brains of rats reportedly undergoes modification at 37 #{176}C, leaving an electrophoretic variant that accounts for most of the residual CK activity. This variant, called CK-BB', migrates on electrophoresis similarly to creatine kinase isoenzyme MB. Using electrophoresis and immunoinhibition with antiserum to creatine kinase isoenzyme MM, we found CK-BB to be the only identifiable cytoplasmic isoenzyme in surgical samples from human brain and intestine. In contrast, we found that some samples of brain obtained at autopsy contain CK-BB'. We also found that CK-BB extracted from human brain was converted to CK-BB' upon incubation in serum or plasma at 37 #{176}C. We found a similar development of CK-BB' in incubation mixtures of serum or plasma containing CK-BB obtained from surgical samples of human intestine. The development of CK-BB' during infarction of the gastrointestinal system may thus be a source of false-positive CK-MB in the laboratory verification of myocardial infarction when electrophoresis is used as the only method to identify CK isoenzymes.
released in vivo is in the event of gastrointestinal infarction. After corroborating the findings of others, using an extract of human brain taken at surgery (8), we proceeded to study the stability of CK-BB extracted from intestine upon incubation at 37#{176}C in serum and plasma.
Because the CK isoenzyme distribution in brain and intestine has not been well-established, it was necessary to investigate this prior to stability studies. Some researchers (9) have proposed that brain contains CK-MM in addition to CK-BB; others (10), using immunological methods, have found CK-BB to be the sole cytoplasmic isoenzyme in several tissues, including brain and intestine. In addition to stability studies, we present our analysis of both autopsy and surgical specimens of brain and intestine by electrophoretic and immunological methods.
Materials and Methods
Specimens of brain were obtained at autopsy or surgery. The autopsy specimens, obtained within 12 h postmortem, were cut into small portions, and stored in liquid nitrogen until use. Surgical specimens from brain and the gastrointestinal tract were transported on ice, cut into strips less than 1 cm x 1 cm, and stored in liquid nitrogen. Before extracting CK isoenzymes, we let the tissue thaw on ice, and measured its wet weight. We then added pH 7.4 buffer (per liter, 0.25 mol of sucrose, 10 mol of Ti-is, 1 mol of ethylene glycol bis(f3-anuinoethyl ether)-N,N,N',N'-tetraacetic acid, and 1 mmol of p-mercaptoethanol), 1.0 or 10.0 mL per gram of tissue, depending on the desired enzyme activity and ease of homogenization (11). The tissue, on ice, was homogenized with a Kinematica GmbH homogenizer (Brinkmann Instruments, Westbury, NY 11590), in 15-s bursts. We centrifuged the homogenate at approximately 10 000 x g for 20 miii at 4#{176}C, then at 100000 xgfor3o mm at4#{176}C to obtain the cytosolic fraction. The pH of the supernate was increased to pH 7.8 ±0.1 with 0.1 mol/L Ti-is solution, and the supernate was either used immediately or frozen (-20 #{176}C) for later use.
We prepared a standard marker for mitochondrial CK by using brain tissue obtained at autopsy, according to Wevers (12). Other standard markers included extract of human skeletal muscle prepared as described above and commercial isoenzyme control (Ciba-Corning Medical, Medfleld, MA 02052).
Both serum and plasma samples were prepared from blood collected from a single volunteer. Because EDTA and citrate prevent the conversion of CK-BB to an intermediately migrating form (9), we used heparinas the anticoagulant for plasma.
Serum and plasma containing only CK-MM were treated with anti-CK-MM antiserum (Chemicon International, El Segundo, CA 90245). The small residual CK activity after this treatment was subtracted from subsequent measurements. We used the same antiserum in assessing the immunoinhibition of tissue extracts to verifr the absence of CK-MM in samples of brain and intestine.
We measured totalCK activity with the aca (13) and diluted serum samples with enzyme activities >900 U/L To detect and quantify CK isoenzymes, we used electrophoresis on cellulose acetate, with reagents and equipment from Helena Laboratories, Beaumont, TX 77704. This was done according to the manufacturer's instructions, except that we extended the recommended run time from 8 miii to 9.5 mm at 350 V to better separate CK-Mt from CK-MM. We checked for the presence of non-creatine kinase activity by using a substrate reagent lacking creatine phosphate.
In preparation for incubation at 37#{176}C, we mixed 0.1 or 0.2 mL of tissue extract containing CK-BB prepared as above with 0.9 mL of either serum, plasma, distilled water, isotonic saline (NaC1 150 mmolfL), or extraction buffer, then removed an aliquot immediately to measure initial activity. We incubated the remaining mixtures in a water bath at 37#{176}C and removed aliquots at regular intervals, placing them on ice to prevent any further decomposition. Within 45 mm of collection, we measured the total CK activity in the aliquots collected and subjected them to electrophoresis.
In one experiment, we incubated CK-BB in serum con- Fig. 2 . Rapid decrease in CK-BB activity extracted from surgical samples of humanbrainincubated in several media taming citrate, using the extraction methods discussed above. The "citrated serum" for this was obtained from a unit ofthawed citrated plasma by adding excess thrombin to a 60-mL aliquot. All other incubations in serum were done in pooled serum from serum samples with low total CK values. Figure l#{192} shows the unusual electrophoretic patterns that were obtained after homogenization and extraction of brain samples from autopsies. Bands other than CK-BB were noted in 14 of 16 specimens. The cathodal band, migrating similarly to CK-Mt, was noted in 14 of the 16 specimens, with the percent activity ranging from 4% to 80% of total CK activity. In one of the specimens from an autopsy of a patient with extensive intracranial atherosclerosis and numerous infarctions, including a large area of chronic laminar necrosis, an additional intermediate band was observed corresponding to CK-BB' (Figure l#{192}, lane 4) . In this specimen, the fractions were CK-BB 44%, CK-BB' 4%, and the remaining 52% of total activity corresponded to CK-Mt at the cathodal position. We obtained grossly normal human brain tissue from a surgical resection of an oligodendroglioma. After homogenization and extraction of this sample with buffer, we found CK-BB to be the only isoenzyme detectable by electrophoresis, with no inhibition of enzyme activity by anti-CK-MM antiserum. 
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A SERUM Q PLASMA (HEPARIN) Fig. 4 . Change in CK-BB activity from human colonic tissue after incubation in hepannized plasma or in serum BB', as well as an unknown cathodal band that was difficult to distinguish from CK-Mt. Incubation in distilled water gave a moderate rate of decline in activity, with the greatest amount of CK-BB' detected at 4.5 h. CK-BB was considerably more stable in isotonic saline and Tris extraction buffer; we did not detect CK-BB' in either of these mixtures after incubating 8 h.
CK Isoenzymes in Intestinal Specimens
We assayed seven samples of healthy colon removed at surgery. These specimens were located distal to colomc carcinomas but were grossly normal. Two additional intestinal tissues included a specimen of healthy jejunum and a specimen of ischemic colon. The mean total CK activity for healthy colon was 182 U per gram wet weight (range 139-216 UIg). The CK activity for ischemic colon was 104 U/g, or 57% that of healthy colon. Healthy jejunum (38 U/g) had only 20% of the activity of healthy colon. By electrophoresis, the CK isoenzyme composition of all nine intestinal samples, including the ischemic colon, was 100% CK-BB. Treatment of the nine intestinal samples with anti-CK-MM yielded a mean immunoinhibition of 3.0% of total activity, which was within allowable error for our antiserum, indicating absence of the M subunit of CK.
Stability of CK-BB from Human Colon
Figures 4 and 5 summarize the 37#{176}C incubation of CK-BB extracted from healthy human colon in mixtures of serum and heparinized plasma. Similarly to the incubation of CK-BB from brain in serum, the total CK-BB activity from colon decreased rapidly on incubation in serum or heparinized plasma, with only 60% of initial activity remaining at 45 mm, 30% at 90 mm. With colon as a source of CK-BB, we noticed the same development of CK-BB' as described above for CK-BB from brain ( Figure lB. lane 4) . In serum, the intermediately-migrating band, CK-BW, was visible qualitatively by electrophoresis at 45 mm; however, owing to the diffuseness of the band, we were unable accurately to quantifr the fraction of CK-BB' until 3 h, at which point CK-BB' was 33% of the residual CK activity (Figures 4 and 5) . On incubation of CK-BB from colon in heparinized plasma, CK-BB' was first detected at 3 h; reported colon to contain 23-32% CK-MM and 31-36% CK-MB by electrophoresis in autopsy samples. The conflicting reports may be adequately explained by the confusion created by CK-Mt and CK-BB. Postmortem change, or antemortem ischeinia, undoubtedly contributed to the prevalence of CK-Mt in our autopsy series of brain. In tissues with significant proportions of CK-BB, postmortem or ischemia-induced changes could also be responsible for production of interfering CK-BB', as we believe occurred in one of our autopsy specimens.
Similar to the findings of Lott and Heinz (7) , as well as others (2-6), we found that CK-BB extractedfrom human brain, when incubated at 37#{176}C in serum, rapidly decreased in activity with the concomitant identification of the electrophoretic variant CK-BB'. In addition to CK-BB' we observed a minor cathodal band, which we were unable to distinguish from CK-Mt or CK-MM. We do not know the identity or significance of this minor electrophoretic band located near the origin.
One could assume that CK-BB from any tissue source would undergo transformation to CK-BB'. We have demonstrated that the in vitro conversion, at least, occurs with CK-BB from human colon obtained at surgery. An increase in serum CK-BB after gastrointestinal infarction has been produced experimentally in dogs (14-16) and observed clinically (17) . If a significant amount of CK-BB is released, and if the in vitro model of incubation at 37 #{176}C in plasma is valid, then the formation of CK-BB' in vivo is likely. Because CK-BB' migrates similarly to CK-MB upon electrophoresis, it could be falsely identified as CK-MB. This phenomenon may account for the peak in "CK-MB" that Graeber et al. (14) report to occur 12 h after experimental gastrointestinal infarction, or 6 h after the peak release of CK-BB.
CK isoenzyme analysis is widely used in the laboratory for confirmation of myocardial infarction. In evaluations of myocardial infarction, it is essential that the entire CK electrophoretic pattern be taken into account.This includes paying due attention to CK-BB, if present. Gibson and Schnur (18) reported a clinical case of lung cancer without evidence of myocardial injury in which they found a persistently increased "CK-MB" electrophoretic fraction, which made up more than 50% of the total CK enzyme activity. In addition to a CK-immunoglobulin complex, we (19) proposed that the presence of CK-BB' could account for the atypical CK band. Also, another case of atypically elevated "CK-MB" without evidence of acute cardiacdisease has been reported (20) in association with unusually elevated CK-BB (50-70% of total activity). The presence of an increased CK-BB fraction, such as with gastrointestinal infarction or in the presence of certain neoplasms, should signal the investigator to be wary of variants such as CK-BB' or CK-BB immunoglobulin complexes and to consider what pathological process could be causing the increased CK-BB.
